14 Sep 2010 16:19

Â
Â
Â
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
Â
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Ark Therapeutics Group Plc |
Â
2 Reason for the notification (please tick the appropriate box or boxes): | ||
 An acquisition or disposal of voting rights | YES | |
 An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |
 An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |
 An event changing the breakdown of voting rights |
| |
 Other (please specify): |
|
|
Â
3. Full name of person(s) subject to the notification obligation: Â | J O Hambro Capital Management Group Limited |
4. Full name of shareholder(s) (if different from 3.): Â |
|
5. Date of the transaction and date on which the threshold is crossed or reached: Â | 9 September 2010 |
6. Date on which issuer notified: Â | 13 September 2010 Â |
7. Threshold(s) that is/are crossed or reached: Â | Below 10% |
Â
8. Notified details: | |||||||
A: Voting rights attached to shares  | |||||||
Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | |||||
Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights | |||
Direct | Direct | Indirect | Direct | Indirect | |||
Ordinary | 21,676,602 | 21,676,602 | 20,659,450 | 20,659,450 |
| 9.87% | |
Sedol: 3425172 |
Â
B: Qualifying Financial Instruments | ||||
Resulting situation after the triggering transaction  | ||||
Type of financial instrument | Expiration date | Exercise/ Conversion Period | Number of voting rights that may be acquired if the instrument is exercised/ converted. Â | % of voting rights |
|
|
|
|
|
Â
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||
Resulting situation after the triggering transaction  | ||||||
Type of financial instrument | Exercise price | Expiration date | Exercise/ Conversion period | Number of voting rights instrument refers to | % of voting rights  | |
|
|
|
|
| Nominal | Delta  |
|
|
Â
Total (A+B+C) Â | |
Number of voting rights | Percentage of voting rights |
20,659,450 | 9.87% |
Â
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
Not applicable |
Â
Proxy Voting: Â | |
10. Name of the proxy holder: Â | - |
11. Number of voting rights proxy holder will cease to hold: Â | - |
12. Date on which proxy holder will cease to hold voting rights: Â | - |
Â
13. Additional information: |
|
14. Contact name: Â | Mark Purnell |
15. Contact telephone number: Â | 020 7747 8952 |
Â